Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Dive

Showing results (41-50 of 207) with videos related to

Pageof 21
Sort By:
Cell Death and Differentiation|April 14, 1999
Comparative effects of Bcl-2 over-expression and ZVAD.FMK treatment on dexamethasone and VP16-induced apoptosis in CEM cellsR S Benson, C Dive, A J Watson
Current Cancer Drug Targets|January 29, 2008
IAPs as a target for anticancer therapyS Danson, E Dean, C Dive, et al.
The Journal of Cell Biology|April 1, 1994
Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator nafenopinA C Bayly, R A Roberts, C Dive
Journal of the National Cancer Institute|January 6, 2000
Epigenetic determinants of resistance to etoposide regulation of Bcl-X(L) and Bax by tumor microenvironmental factorsS T Taylor, J A Hickman, C Dive
Journal of Cell Science|May 13, 1999
Cytoplasmic acidification is not an effector mechanism of VP16 or DEX-induced apoptosis in CEM T leukaemia cellsR S Benson, C Dive, A J Watson
Acta Gastro-Enterologica Belgica|January 1, 1981
[A study of the anorectal motricity: its value in chronic diarrhoea (author's transl)]M Melange, R Vanheuverzwyn, R Fiasse, et al.
Cancer Research|October 1, 1994
The suppression of drug-induced apoptosis by activation of v-ABL protein tyrosine kinaseR S Chapman, A D Whetton, C Dive
Digestive Diseases and Sciences|January 1, 1982
Breath 14CO2 after intravenous administration of [14C]aminopyrine in liver diseasesS Pauwels, A P Geubel, C Dive, et al.
Lymphology|December 1, 1971
Origin and composition of hepatic lymph proteins in the dogC C Dive, A C Nadalini, J F Heremans
Cancer Chemotherapy and Pharmacology|January 1, 1992
Is metabolism an important arbiter of anticancer activity of ether lipids? Metabolism of SRI 62-834 and hexadecylphosphocholine by [31P]-NMR spectroscopy and comparison of their cytotoxicities with those of their metabolitesF E Bishop, C Dive, S Freeman, et al.
Pageof 21

Showing results (41-50 of 207) with videos related to

Sort By:
Pageof 21
Cell Death and Differentiation|April 14, 1999
Comparative effects of Bcl-2 over-expression and ZVAD.FMK treatment on dexamethasone and VP16-induced apoptosis in CEM cellsR S Benson, C Dive, A J Watson
Current Cancer Drug Targets|January 29, 2008
IAPs as a target for anticancer therapyS Danson, E Dean, C Dive, et al.
The Journal of Cell Biology|April 1, 1994
Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator nafenopinA C Bayly, R A Roberts, C Dive
Journal of the National Cancer Institute|January 6, 2000
Epigenetic determinants of resistance to etoposide regulation of Bcl-X(L) and Bax by tumor microenvironmental factorsS T Taylor, J A Hickman, C Dive
Journal of Cell Science|May 13, 1999
Cytoplasmic acidification is not an effector mechanism of VP16 or DEX-induced apoptosis in CEM T leukaemia cellsR S Benson, C Dive, A J Watson
Acta Gastro-Enterologica Belgica|January 1, 1981
[A study of the anorectal motricity: its value in chronic diarrhoea (author's transl)]M Melange, R Vanheuverzwyn, R Fiasse, et al.
Cancer Research|October 1, 1994
The suppression of drug-induced apoptosis by activation of v-ABL protein tyrosine kinaseR S Chapman, A D Whetton, C Dive
Digestive Diseases and Sciences|January 1, 1982
Breath 14CO2 after intravenous administration of [14C]aminopyrine in liver diseasesS Pauwels, A P Geubel, C Dive, et al.
Lymphology|December 1, 1971
Origin and composition of hepatic lymph proteins in the dogC C Dive, A C Nadalini, J F Heremans
Cancer Chemotherapy and Pharmacology|January 1, 1992
Is metabolism an important arbiter of anticancer activity of ether lipids? Metabolism of SRI 62-834 and hexadecylphosphocholine by [31P]-NMR spectroscopy and comparison of their cytotoxicities with those of their metabolitesF E Bishop, C Dive, S Freeman, et al.
Pageof 21